Article info
Electronic pages
Correspondence
Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years
- Correspondence to Dr Motohisa Yamamoto, Division of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, South 1-West 16, Chuo-ku, Sapporo, Hokkaido 0608543, Japan; mocha{at}cocoa.plala.or.jp
Citation
Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years
Publication history
- Received March 20, 2015
- Accepted March 23, 2015
- First published April 10, 2015.
Online issue publication
June 30, 2016
Article Versions
- Previous version (30 June 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions